Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Systemic

Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.

452 public trials 124 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Systemic trial results

Active, not recruiting

A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease

NCT06544330

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Feinstein Institutes for Medical Research Manhasset, New York, United States
  • Columbia University Irving Medical Center New York, United States
View Trial Details
Active, not recruiting

A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

NCT06255028

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +27 more
Locations
  • Keck School of Medicine of University of Southern California Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Lurie Children's; Northwestern Medicine - Northwestern Medical Group Chicago, Illinois, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Active, not recruiting

A Study of MT-0551 in Patients With Systemic Sclerosis

NCT05198557

Conditions
Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations
  • University of Fukui Hospital Yoshida-gun, Fukui, Japan
  • Kanazawa University Hospital Kanazawa, Ishikawa-ken, Japan
  • St. Marianna University Hospital Kawasaki-shi, Kanagawa, Japan
  • The University of Tokyo Hospital Bunkyo-ku, Tokyo, Japan
View Trial Details

Related conditions